Safety and efficacy of pregabalin in adolescents with fibromyalgia: a randomized double-blind placebo-controlled trial and a 6-month open-label extension study

摘要

BackgroundFibromyalgia (FM) is a common pain condition characterized by widespread musculoskeletal pain and tenderness. Pregabalin is an approved treatment for adults in the United States, but there are no approved treatments for adolescents with FM.